Moreover, such an elevation of cardiomyocyte-derived circulating FGF23 resulting from cardiac hypertrophy may not only alter phosphate homeostasis but also increase the overall metabolic burden, as well as hypertension and hemodynamic abnormalities. This evidence concerns the gene FGF23 and Hypertension.